Histologic Grade
TERMINOLOGY
Abbreviations
Elston and Ellis modification of Scarff-Bloom-Richardson histologic grading (MSBR)
Synonyms
Elston and Ellis grading
Modified Bloom-Richardson grade
Nottingham combined histologic grade
INTRODUCTION
Grade and Breast Cancer
MSBR is most widely used system for breast tumor grading
Recommended by College of American Pathologists, American Joint Committee on Cancer, and European Commission Working Group on Breast Screening Pathology
Grading divides breast cancers into groups that have different natural histories and biologic characteristics
MSBR grade describes features related to tumor differentiation and proliferation
Grade 1(well differentiated): 20% of cancers
Incidence higher in older &/or screened populations
Grade 2 (moderately differentiated): 30-35% of cancers
Grade 3 (poorly differentiated): 45-50% of cancers
Incidence higher in younger &/or unscreened populations
Other grading systems have been described but have not been as widely used or validated with as many studies as MSBR
Prognosis and Grade
Histologic grade is strongly correlated with breast cancer-specific survival and disease-free survival
Many clinical studies have validated and confirmed important prognostic significance of tumor grade
Significant association between grade and survival holds true for different tumor subgroups
Tumor size (pT1a, pT1b, pT1c, and pT2)
Lymph node stages (pN0, pN1, and pN2)
Grade correlated with overall length of survival regardless of clinical stage
ETIOLOGY/PATHOGENESIS
Grade and Genomic Grade Index (GGI)
GGI was developed using gene expression profiling
97 genes were found to be differentially expressed between low and high histologic grade carcinomas
Majority of genes are associated with cell cycle regulation and proliferation
Low and high GGI strongly associated with disease-free and overall survival in ER-positive cancers
Low GGI found in luminal A cancers
High GGI found in luminal B, HER2, and basal-like cancers
Low and high GGI associated with histologic grade
Histologic grade 1: ˜ 85% low GGI
Histologic grade 3: ˜ 90% high GGI
GGI reclassified histologic grade 2 carcinomas into 2 groups
Approximately 2/3 were low GGI and had outcomes similar to other low-grade cancers
Approximately 1/3 were high GGI and had outcomes similar to other high-grade cancers
GGI has challenged clinical relevance of grade 2 category
GGI has helped validate histologic grade as important prognostic factor
Provides molecular basis underlying different grades of breast cancer
Simplified index using 4 genes associated with cell cycle progression and proliferation is determined
using qRT-PCR (“PCR-GGI”) and can be used to analyze formalin fixed tissue
Genes used are MYBL2 (also used in Oncotype DX [Genomic Health; Redwood City, CA]), KPNA2 (also used in Mammaprint [Agendia; Irvine, CA]), CDC2, and CDC20
Results are similar to 97 gene assay
Histologic grade 2 carcinomas can also be subdivided by other measures of proliferation
Ki-67 (MIB-1) is positive in all cycling cells (i.e., all cells not in G0)
Histologic grade 1: 1-15% positive cells (mean ˜ 10%)
Histologic grade 2: 3-40% positive cells (mean ˜ 10%)
Histologic grade 3: 8-85% positive cells (mean ˜ 20%)
Grade 2 cancers can be divided into 2 groups based on Ki-67 scores; generally, cut-off point of 15% is used
Grade and Changes in DNA
Number and pattern of genomic copy number alterations differed significantly when stratified by grade
Average number of chromosomal changes increases with increasing grade
Low-grade carcinomas had fewer genomic alterations
Close correlation between DNA copy number and mRNA expression levels has been reported
Gene amplification may be common mechanism for increased gene expression in breast tumors
May help explain GGI
Genomic changes provide further validation for histologic grade as important prognostic factor
MICROSCOPIC FINDINGS
MSBR Grading
3 features are evaluated separately; given scores of 1-3
Sum of scores determines final grade
MSBR (Sum of the Scores)
MSBR grade 1 (sum of scores = 3-5)
Well-differentiated breast cancer
MSBR grade 2 (sum of scores = 6-7)
Moderately differentiated breast cancerStay updated, free articles. Join our Telegram channel
Full access? Get Clinical Tree